Studien

CANOPY-2

Phase III Study Evaluating Efficacy and Safety of Canakinumab in Combination With Docetaxel in Adult Subjects With Non-small Cell Lung Cancers as a Second or Third Line Therapy

CANOPY-A

Phase III study of canakinumab (CAN) as adjuvant therapy in patients (pts) with completely resected non-small cell lung cancer (NSCLC)

CANOX

Multicentre randomised placebo-controlled trial of nocturnal oxygen therapy in chronic obstructive pulmonary disease

CANPAP

CANadian continuous Posive Airway Pressure trial for congestive heart failure patients with central sleep apnea

CANPIONE

CANagliflozin in type 2 diabetic PatIents with micrOalbuminuria in JapaNEse population

CANPOP

A clinical trial as proof of principle of the analgesic effectiveness of cannabinoids on postoperative pain

CanPREDDICT

Canadian study of prediction of death, dialysis and interim cardiovascular events

CANRACE

Canadian Registry of Acute Coronary Events Investigators

CanREACH

Canadian Research and Education for the Advancement of Child Health

CANREO-PMO

Potassium canrenoate in brain-dead organ donors

CanRIO

Canadian Research Group of Rheumatology in Immuno-Oncology

CanSPUC

Cancer Screening Program in Urban China

CanTalk

The clinical and cost effectiveness of cognitive behavioural therapy plus treatment as usual for the treatment of depression in advanced cancer

CANTATA

CB-839 With Cabozantinib vs. Cabozantinib With Placebo in Patients With Metastatic Renal Cell Carcinoma

CANTATA-SU

CANagliflozin Treatment And Trial Analysis versus SUlphonylurea

CANTHANOX

Comparison of low-molecular-weight heparin and warfarin for the secondary prevention of venous thromboembolism in patients with cancer

CANTIC

Platelet Inhibition With Cangrelor and Crushed Ticagrelor in STEMI

CANTOS

Canakinumab ANti-inflammatory Thrombosis Outcomes Study. Cardiovascular Risk Reduction Study (Reduction in Recurrent Major CV Disease Events)

CANUSA

CANada-USA peritoneal dialysis study

CANVAS

CANagliflozin cardioVascular Assessment Study

CANVAS

Choice of ANesthesia for EndoVAScular Treatment of Acute Ischemic Stroke

CANVAS

CMV Modulation of the Immune System in ANCA-associated Vasculitis

CANVAS

Comparative study of Ceftaroline vs. Vancomycin plus Aztreonam in Adult Subjects with complicated Skin infections

CANVAS

Direct Oral Anticoagulants (DOACs) Versus LMWH +/- Warfarin for VTE in Cancer

CANVAS II

Choice of Anesthesia for Endovascular Treatment of Acute Ischemic Stroke in Posterior Circulation

CANVAS-R

CANagliflozin cardioVascular Assessment Study-Renal

CANWARD

Canadian Ward Surveillance Study

CAO/ARO/AIO-04

Oxaliplatin added to fluorouracil-based preoperative chemoradiotherapy and postoperative chemotherapy of locally advanced rectal cancer. German Rectal Cancer Study Group

CAO/ARO/AIO-12

Working Group of Surgical Oncology/Working Group of Radiation Oncology/Working Group of Medical Oncology of the Germany Cancer Society-12

CAO/ARO/AIO-94

Working Group of Surgical Oncology/Working Group of Radiation Oncology/Working Group of Medical Oncology of the Germany Cancer Society-94

CAP

Caffeine for Apnea of Prematurity

CAP

Cholesterol And Pharmacogenetics

CAP

Cluster Randomized Trial of PSA Testing for Prostate Cancer

CAP

Comparative Atorvastatin Pleiotropic effects study

CAP

Comparing compression, perclose proglide™ and Angio-Seal VIP™ for arterial closure following percutaneous coronary intervention

CAP

Corticoids in Severe Community-Acquired Pneumonia

CAP 01

Camrelizumab Combined With Apatinib for Recurrent Resistant Gestational Trophoblastic Neoplasia

CAP 02

Study of Anti-PD-1 Antibody SHR-1210 Plus Apatinib as Second-Line Treatment of Advanced Esophageal Squamous Cell

CAP 03

Camrelizumab Plus Apatinib and Temozolomide as First Line Therapy in Advanced Acral Melanoma

CAP-IN

Community-Acquired Pneumonia trial

CAP-IT

Amoxicillin duration and dose for community-acquired pneumonia in children

CAP-PACT

Increasing Community-acquired Pneumonia Protocol Adherence by Antibiotic Stewardship

CAP-START

Community-Acquired Pneumonia - Study on the initial Treatment with Antibiotics of lower Respiratory Tract infections

CAP2

Continued Access to PREVAIL (CAP2) - WATCHMAN Left Atrial Appendage (LAA) Closure Technology

CAPABLE

Caduet in simultaneously Achieving Blood Pressure and Lipid Endpoints in a specific patient population study

CAPABLE

Clinical utility of Caduet in simultaneously Achieving blood Pressure and Lipid End points trial

CAPACITY

Association of Changes in Plasma Neurofilament Light and Tau Levels With Anesthesia and Surgery

CapaCiTY

Chronic Constipation Treatment Pathway

CAPACITY

Pirfenidone in patients with idiopathic pulmonary fibrosis

CAPACITY HFpEF

A Study of the Effect of IW-1973 on the Exercise Capacity of Patients With Heart Failure With Preserved Ejection Fraction (HFpEF)

CAPACITY-COVID

Cardiac complicAtions in Patients With SARS Corona vIrus 2 (COVID-19) regisTrY

CAPARES

Coronary AngioPlasty Amlodipine REstenosis Study

CAPE

Circadian Antiischemia Program in Europe

CAPE COD

Community-Acquired Pneumonia: Evaluation of COrticosteroiDs

CAPE COVID

Community-Acquired Pneumonia: Evaluation of COrticosteroiDs

CAPE II

Circadian Antiischemia Program in Europe II

CAPE III

Circadian Antiischemia Program in Europe III

CAPE-BD

Treatment for Bipolar Depression: Acute & Prophylactic Efficacy With Citalopram

CAPELLA

Intravitreal Combined Aflibercept + Anti–Platelet-Derived Growth Factor Receptor β for Neovascular Age-Related Macular Degeneration

CAPELLA

Study to Evaluate the Safety and Efficacy of Lenacapavir (GS-6207) in Combination With an Optimized Background Regimen (OBR) in Heavily Treatment Experienced Participants Living With HIV-1 Infection With Multidrug Resistance